Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma.

Kazuyuki Mizuno Norihiro ImaiTakafumi YamamotoShinya YokoyamaKenta YamamotoTakanori ItoYoji IshizuTakashi HondaTeiji KuzuyaMasatoshi IshigamiHiroki Kawashima

Published in: Cancers (2023)

Pretreatment proteinuria predicts a poorer prognosis in patients with unresectable HCC treated with lenvatinib or atezolizumab plus bevacizumab but not in those treated with sorafenib.

Keyphrases

locally advanced
liver metastases
rectal cancer
radiation therapy